العاصمة قرض تغيير تاريخ
AbbVie USD 64.53B 5.59B 2026-03
Agenus USD 169.66M 146.06M 2025-12
Amgen USD 51.89B 1.88B 2026-03
AstraZeneca USD 26.01B 46M 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
CSL USD 10.42B 273M 2025-12
Eli Lilly USD 39.37B 1.5B 2026-03
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 13.95B 65M 2026-06
Glaxosmithkline GBP 18.53B 1.29B 2026-03
Incyte USD 28.42M 994K 2026-06
Intrexon USD 0 198.67M 2024-06
J&J USD 37.34B 183M 2026-06
Jiangsu Hengrui CNY 37.1M 6.2M 2026-03
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
MacroGenics USD 68.71M 1.29M 2026-03
Merck EUR 10.8B 72M 2026-03
Merck USD 46.67B 77M 2026-03
Northwest Biotherapeutics USD 31.8M 11.49M 2025-09
Novartis USD 37.49B 42M 2026-06
Novavax USD 246.3M 200K 2025-12
Pfizer USD 60.57B 1.08B 2026-03
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Rigel Pharmaceuticals USD 0 0 2024-09
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 0 0 2025-03